Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay.
about
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agentsIdentification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions.Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer.Chemotherapy for malignant gliomas based on histoculture drug response assay : a pilot studyThe apoptotic effects of sirtuin1 inhibitor on the MCF-7 and MRC-5 cell lines.Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor - belinostat - in glioblastoma cell lines: a preliminary report.Combination of Salermide and Cholera Toxin B Induce Apoptosis in MCF-7 but Not in MRC-5 Cell Lines.Incidence trends and predictors for cost and average lengths of stay in colorectal cancer surgery.Characterization of biological responses of colorectal cancer cells to anticancer regimens.Genome-wide identification of chemosensitive single nucleotide polymorphism markers in colorectal cancers.Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells.Activity of superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase in different stages of colorectal carcinoma.
P2860
Q21198868-4C6257A2-2344-42DC-8881-B708B028339EQ30541685-6CE4AF92-5CF5-4192-AF28-699BABCAC822Q34297701-91855F3B-56C8-4D63-9742-6AAE18B71BB4Q35675900-80E9C189-373E-4229-BCE8-5DB9FF0DA565Q37150846-3E40AE4F-C01F-4CD8-8EDC-BC430769D2DFQ37222794-EF323F88-85E1-4743-AE8F-6E462DAAFEDAQ37503038-DBE44A6D-1E39-4914-9B79-17EEFD0ED6A3Q37581369-F18C1356-5AA8-4B3B-BCF4-9E902F95F3CFQ41911162-B897FDDB-F712-4182-A90F-1D05604E4BAAQ43189894-5718B656-A9B1-4AFC-8029-26C302F8CB90Q48119543-24ADB47B-AD4D-4900-8BE7-15304989F246Q51034383-DA6A609C-7A9A-4024-A448-2CAA020338E5
P2860
Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Evaluation of novel histone de ...... toculture drug response assay.
@en
Evaluation of novel histone de ...... toculture drug response assay.
@nl
type
label
Evaluation of novel histone de ...... toculture drug response assay.
@en
Evaluation of novel histone de ...... toculture drug response assay.
@nl
prefLabel
Evaluation of novel histone de ...... toculture drug response assay.
@en
Evaluation of novel histone de ...... toculture drug response assay.
@nl
P2093
P1476
Evaluation of novel histone de ...... toculture drug response assay.
@en
P2093
Dong H Cho
Jung S Lee
Moon B Kim
Seon Y Kim
Seong G Ro
Yong S Kim
P2860
P2888
P304
P356
10.1007/S00384-008-0590-1
P577
2008-10-01T00:00:00Z